Martine E D Chamuleau (M E D Chamuleau)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Diffuse Large B Cell Lymphoma

Prognostic Factors

Cross Sectional

Top Venues

Blood cancer journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Elise R A Pennings, Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Djamila E Issa, Martine E D Chamuleau, Pieternella J Lugtenburg, Marie José Kersten, Avinash G Dinmohamed
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands. Blood cancer journal 14 (1) (2024)
Carolien C H M Maas, David van Klaveren, Müjde Durmaz, Otto Visser, Djamila E Issa, Eduardus F M Posthuma, Josée M Zijlstra, Martine E D Chamuleau, Pieternella J Lugtenburg, Marie José Kersten, Avinash G Dinmohamed
Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma. Blood cancer journal 14 (1) (2024)
A Vera de Jonge, J A A Bult, D F E Karssing, Marcel Nijland, Martine E D Chamuleau, Mirian Brink
A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma. Blood cancer journal 14 (1) (2024)
Elise R A Pennings, Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Djamila E Issa, Martine E D Chamuleau, Pieternella J Lugtenburg, Marie José Kersten, Avinash G Dinmohamed
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands. Blood cancer journal 14 (1) (2024)
Elise R A Pennings, Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Djamila E Issa, Martine E D Chamuleau, Pieternella J Lugtenburg, Marie José Kersten, Avinash G Dinmohamed
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands. Blood cancer journal 14 (1) (2024)
A Vera de Jonge, J A A Bult, D F E Karssing, Marcel Nijland, Martine E D Chamuleau, Mirian Brink
A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma. Blood cancer journal 14 (1) (2024)
A Vera de Jonge, J A A Bult, D F E Karssing, Marcel Nijland, Martine E D Chamuleau, Mirian Brink
A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma. Blood cancer journal 14 (1) (2024)
Elise R A Pennings, Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Djamila E Issa, Martine E D Chamuleau, Pieternella J Lugtenburg, Marie José Kersten, Avinash G Dinmohamed
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands. Blood cancer journal 14 (1) (2024)
A Vera de Jonge, J A A Bult, D F E Karssing, Marcel Nijland, Martine E D Chamuleau, Mirian Brink
A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma. Blood cancer journal 14 (1) (2024)
A Vera de Jonge, Erik D van Werkhoven, Avinash G Dinmohamed, Marcel Nijland, Aeilko H Zwinderman, Patrick M Bossuyt, Martine S Veldhuis, Emma G G M Rutten, Rogier Mous, Joost S P Vermaat, Yorick Sandberg, Eva de Jongh, Yavuz M Bilgin, Rinske Boersma, Harry Koene, Marie José Kersten, Daphne de Jong, Martine E D Chamuleau
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients. Blood cancer journal 13 (1) (2023)
Johanna A A Bult, Francien Huisman, Yujie Zhong, Nick Veltmaat, Joost Kluiver, Sanne H Tonino, Joost S P Vermaat, Martine E D Chamuleau, Arjan Diepstra, Anke van den Berg, Wouter J Plattel, Mirian Brink, Marcel Nijland
A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics. Blood cancer journal 13 (1) (2023)
Fleur A de Groot, Ruben A L de Groen, Anke van den Berg, Patty M Jansen, King H Lam, Pim G N J Mutsaers, Carel J M van Noesel, Martine E D Chamuleau, Wendy B C Stevens, Jessica Rodrigues Plaça, Rogier Mous, Marie José Kersten, Marjolein M W van der Poel, Thomas A Tousseyn, F J S H Sherida Woei-A-Jin, Arjan Diepstra, Marcel Nijland, Joost S P Vermaat
Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach. Cancers 14 (8) (2022)
Diana Al-Sarayfi, Frederik O Meeuwes, Müjde Durmaz, Djamila E Issa, Rolf E Brouwer, Aart Beeker, Anna van Rhenen, Pim G N J Mutsaers, Lara H Böhmer, Marjolein W M van der Poel, Liane Te Boome, Tom van Meerten, Martine E D Chamuleau, Josée M Zijlstra, Mirian Brink, Marcel Nijland
R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma. Blood cancer journal 12 (9) (2022)
Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Rolf E Brouwer, Djamila E Issa, Daphne de Jong, King H Lam, Nicole M A Blijlevens, Josée M Zijlstra, Martine E D Chamuleau, Pieternella J Lugtenburg, Marie José Kersten, Avinash G Dinmohamed
Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989-2018. Blood cancer journal 12 (3) (2022)
Jakoba Johanna Eertink, Anne I J Arens, J E Huijbregts, Filiz Celik, Bart de Keizer, Sigrid Stroobants, Daphne de Jong, Sanne Elisabeth Wiegers, Gerben J C Zwezerijnen, Coreline N Burggraaff, Ronald Boellaard, Henrica C W de Vet, Otto S Hoekstra, Pieternella J Lugtenburg, Martine E D Chamuleau, J M Zijlstra, null null
Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements. European journal of nuclear medicine and molecular imaging (2021)
D E Issa, Rianne Seefat, O Visser, Sonja Zweegman, P J Lugtenburg, Avinash G Dinmohamed, Martine E D Chamuleau
Primary therapy and survival in patients with Burkitt lymphoma in The Netherlands: a population-based study, 1989-2018. Blood 137 (20) (2021)
Marie José Kersten, Karima Amaador, Monique C Minnema, Josephine M I Vos, Kazem Nasserinejad, Marcel Kap, Efstathios Kastritis, Maria Gavriatopoulou, Willem Kraan, Martine E D Chamuleau, Dries Deeren, Lidwine W Tick, Jeanette K Doorduijn, Fritz Offner, Lara H Böhmer, Roberto D Liu, Steven T Pals, Meletios- Athanasios Dimopoulos
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)